Anzeige
Mehr »
Freitag, 27.06.2025 - Börsentäglich über 12.000 News
Blockbuster-Bohrergebnisse: Gold-Antimon-Fund in Nevada trifft geopolitischen Nerv
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2DX1V | ISIN: US98887Q1040 | Ticker-Symbol: 1ZL
Tradegate
25.06.25 | 21:56
31,600 Euro
+1,94 % +0,600
1-Jahres-Chart
ZAI LAB LTD ADR Chart 1 Jahr
5-Tage-Chart
ZAI LAB LTD ADR 5-Tage-Chart
RealtimeGeldBriefZeit
29,80030,00020:24
29,80030,00020:21

Aktuelle News zur ZAI LAB LTD ADR Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
ZAI LAB LTD ADR Aktie jetzt für 0€ handeln
10:43ZAI LAB (09688): RESIGNATION OF JOINT COMPANY SECRETARY AND CHANGE OF AUTHORISED REPRESENTATIVE2
19.06.ZAI LAB (09688): NEXT DAY DISCLOSURE RETURN2
19.06.ZAI LAB (09688): GRANT OF RESTRICTED SHARES2
19.06.ZAI LAB (09688): VOTING RESULTS OF ANNUAL GENERAL MEETING1
18.06.Zai Lab Ltd - 8-K, Current Report2
13.06.Zai Lab Limited: Zai Lab Presents New Preclinical Data for ZL-1503, an IL-13/IL-31R Bispecific Antibody for the Treatment of Atopic Dermatitis, at EAACI Congress 2025263-Data highlights potential of ZL-1503 as a promising treatment for moderate-to-severe atopic dermatitis and other IL-13 and IL-31-driven diseases -Favorable preclinical safety profile, prolonged...
► Artikel lesen
11.06.Citi Trims Zai Lab TP to US$66, Rating Buy3
11.06.BofAS Elevates TPs for ZAI LAB/TIGERMED to HKD29.61/HKD40.12
06.06.BofAS Raises ZAI LAB's TP to HKD29.61; Rating Reiterated Neutral1
05.06.ZAI LAB (09688): GRANT OF SHARE OPTIONS AND RESTRICTED SHARE UNITS1
02.06.Zai Lab auf der ASCO 2025: Vielversprechende Neuigkeiten zu Lungenkrebs-Medikament6
01.06.Zai Lab Limited (ZLAB) & NovoCure Limited (NVCR)'s TTFields Therapy Succeeds in Phase 3 Trial5
31.05.Zai Lab Limited: Zai Lab and Novocure Announce Results From the Phase 3 PANOVA-3 Trial of Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer to be Presented at 2025 ASCO Annual Meeting798TTFields therapy concomitant with gemcitabine and nab-paclitaxel is the first treatment to show a clinically meaningful and statistically significant improvement in overall survival (OS) for...
► Artikel lesen
20.05.FDA grants fast track status to Zai Lab's lung cancer treatment4
19.05.Zai Lab gets FDA fast track status for lung cancer treatment2
19.05.Zai Lab Gets FDA Fast Track Status For ZL-1310 To Treat Extensive-stage Small Cell Lung Cancer380BEIJING (dpa-AFX) - Zai Lab Limited (ZLAB) Monday said that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to ZL-1310 for the treatment of extensive-stage small...
► Artikel lesen
14.05.ZAI LAB (09688): GRANT OF RESTRICTED SHARE UNITS-
08.05.ZAI LAB (09688): OVERSEAS REGULATORY ANNOUNCEMENT - FORM 10-Q3
08.05.Zai Lab Limited Q1 Loss Decreases, Beats Estimates318BEIJING (dpa-AFX) - Zai Lab Limited (ZLAB) announced Loss for first quarter that decreased from last year and beat the Street estimates.The company's bottom line came in at -$48.438 million...
► Artikel lesen
08.05.ZAI LAB (09688): UNAUDITED RESULTS FOR THE THREE MONTHS ENDED MARCH 31, 2025 AND CORPORATE UPDATES3
Weiter >>
85 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,2